$Tonix Pharmaceuticals(TNXP)$

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

TigerGPT
11-20
TigerGPT
Tonix Pharmaceuticals (TNXP) Overview
Tonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions.
Recent News and Events
Here are some of the recent news and events related to Tonix Pharmaceuticals:
Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. Link to Article

ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. Link to Article

Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. Link to Article

Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. Link to Article

BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. Link to Article

Conclusion
Tonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions.
Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Barcode
11-20
Barcode
🙌 🙌 🙌 Awesome Kallu! Huge gains! Congrats 🥂 🩵
- Kallu:
  Thanks boss!! But investment is too low 😂 regretting now
Tiger_CashBoostAccount
11-21
Tiger_CashBoostAccount
Your recent success is a great motivator. Keep refining your investment strategies and making those smart moves. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.
Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Other helpful links:

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":373078257447032,"tweetId":"373078257447032","gmtCreate":1732093999131,"gmtModify":1732094757800,"author":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"authorIdStr":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.08%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/22666e4b24ab40af2202a7bc068e0ea3","width":"1068","height":"1112"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/22666e4b24ab40af2202a7bc068e0ea3","width":"1068","height":"1112"}],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;<img src=\"https://community-static.tradeup.com/news/22666e4b24ab40af2202a7bc068e0ea3\" tg-width=\"1068\" tg-height=\"1112\"></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;<img src=\"https://community-static.tradeup.com/news/22666e4b24ab40af2202a7bc068e0ea3\" tg-width=\"1068\" tg-height=\"1112\"></body></html>","text":"$Tonix Pharmaceuticals(TNXP)$ $Tonix Pharmaceuticals(TNXP)$ @Barcode @TigerGPT $Tonix Pharmaceuticals(TNXP)$","highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/373078257447032","repostId":0,"isVote":1,"tweetType":1,"viewCount":383,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TNXP"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":101,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":373078302839088,"commentId":"373078302839088","gmtCreate":1732094013937,"gmtModify":1732094022099,"authorId":4141429963588842,"author":{"id":4141429963588842,"idStr":"4141429963588842","authorId":4141429963588842,"name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":373078257447032,"objectIdStr":"373078257447032","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Tonix Pharmaceuticals (TNXP) OverviewTonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions.Recent News and EventsHere are some of the recent news and events related to Tonix Pharmaceuticals:Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. <a href=\"https://ttm.financial/NW/2484989639\">Link to Article</a>&nbsp;&nbsp;ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. <a href=\"https://ttm.financial/NW/2484621444\">Link to Article</a>&nbsp;&nbsp;Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. <a href=\"https://ttm.financial/NW/2483756723\">Link to Article</a>&nbsp;&nbsp;Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. <a href=\"https://ttm.financial/NW/2482584704\">Link to Article</a>&nbsp;&nbsp;BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. <a href=\"https://ttm.financial/NW/2479064674\">Link to Article</a>&nbsp;&nbsp;ConclusionTonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions.Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.","text":"Tonix Pharmaceuticals (TNXP) OverviewTonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions.Recent News and EventsHere are some of the recent news and events related to Tonix Pharmaceuticals:Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. <a href=\"https://ttm.financial/NW/2484989639\">Link to Article</a>&nbsp;&nbsp;ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. <a href=\"https://ttm.financial/NW/2484621444\">Link to Article</a>&nbsp;&nbsp;Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. <a href=\"https://ttm.financial/NW/2483756723\">Link to Article</a>&nbsp;&nbsp;Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. <a href=\"https://ttm.financial/NW/2482584704\">Link to Article</a>&nbsp;&nbsp;BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. <a href=\"https://ttm.financial/NW/2479064674\">Link to Article</a>&nbsp;&nbsp;ConclusionTonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions.Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.","html":"Tonix Pharmaceuticals (TNXP) OverviewTonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions.Recent News and EventsHere are some of the recent news and events related to Tonix Pharmaceuticals:Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. <a href=\"https://ttm.financial/NW/2484989639\">Link to Article</a>&nbsp;&nbsp;ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. <a href=\"https://ttm.financial/NW/2484621444\">Link to Article</a>&nbsp;&nbsp;Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. <a href=\"https://ttm.financial/NW/2483756723\">Link to Article</a>&nbsp;&nbsp;Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. <a href=\"https://ttm.financial/NW/2482584704\">Link to Article</a>&nbsp;&nbsp;BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. <a href=\"https://ttm.financial/NW/2479064674\">Link to Article</a>&nbsp;&nbsp;ConclusionTonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions.Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0},{"id":373079805141192,"commentId":"373079805141192","gmtCreate":1732094395246,"gmtModify":1732094483198,"authorId":4171900329979952,"author":{"id":4171900329979952,"idStr":"4171900329979952","authorId":4171900329979952,"name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","vip":1,"currentWearingBadge":{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.30","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2007},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.22","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":373078257447032,"objectIdStr":"373078257447032","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"🙌 🙌 🙌 Awesome Kallu! Huge gains! Congrats 🥂 🩵","text":"🙌 🙌 🙌 Awesome Kallu! Huge gains! Congrats 🥂 🩵","html":"🙌 🙌 🙌 Awesome Kallu! Huge gains! Congrats 🥂 🩵","likeSize":1,"commentSize":1,"subComments":[{"id":373009451266152,"commentId":"373009451266152","gmtCreate":1732096139149,"gmtModify":1732096143925,"authorId":4156648821928502,"author":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.08%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":373078257447032,"objectIdStr":"373078257447032","type":1,"supId":373079805141192,"supIdStr":"373079805141192","prevId":0,"prevIdStr":"0","content":"Thanks boss!! But investment is too low 😂 regretting now","text":"Thanks boss!! But investment is too low 😂 regretting now","html":"Thanks boss!! But investment is too low 😂 regretting now"}],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0},{"id":373149567606872,"commentId":"373149567606872","gmtCreate":1732119992290,"gmtModify":1732120657585,"authorId":10000000000010968,"author":{"id":10000000000010968,"idStr":"10000000000010968","authorId":10000000000010968,"name":"Tiger_CashBoostAccount","avatar":"https://community-static.tradeup.com/news/ae2d4002ef9664aba005cb3020f416f5","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.22","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":373078257447032,"objectIdStr":"373078257447032","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Your recent success is a great motivator. Keep refining your investment strategies and making those smart moves. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.Other helpful links:<ul style=\"list-style-type: disc;\"><li><a href=\"https://www.itiger.com/sg/help/detail/06324754?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"How to open a CBA.\" class=\"\">How to open a CBA.</a></li><li><a href=\"https://www.itiger.com/sg/help/detail/how-to-link-CDP?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"How to link your CDP account.\" class=\"\">How to link your CDP account.</a></li><li><a href=\"https://www.itiger.com/sg/help/detail/contra-faq?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"Other FAQs on CBA.\" class=\"\">Other FAQs on CBA.</a></li><li><a href=\"https://www.itiger.com/sg/invest/cash-boost\" title=\"Cash Boost Account Website.\" class=\"\">Cash Boost Account Website.</a><img src=\"https://community-static.tradeup.com/news/9cacb64c02a7bc16143db1b24ccaf6e6\" tg-width=\"1080\" tg-height=\"1080\"></li></ul>","text":"Your recent success is a great motivator. Keep refining your investment strategies and making those smart moves. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.Other helpful links:<ul style=\"list-style-type: disc;\"><li><a href=\"https://www.itiger.com/sg/help/detail/06324754?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"How to open a CBA.\" class=\"\">How to open a CBA.</a></li><li><a href=\"https://www.itiger.com/sg/help/detail/how-to-link-CDP?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"How to link your CDP account.\" class=\"\">How to link your CDP account.</a></li><li><a href=\"https://www.itiger.com/sg/help/detail/contra-faq?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"Other FAQs on CBA.\" class=\"\">Other FAQs on CBA.</a></li><li><a href=\"https://www.itiger.com/sg/invest/cash-boost\" title=\"Cash Boost Account Website.\" class=\"\">Cash Boost Account Website.</a><img src=\"https://community-static.tradeup.com/news/9cacb64c02a7bc16143db1b24ccaf6e6\" tg-width=\"1080\" tg-height=\"1080\"></li></ul>","html":"Your recent success is a great motivator. Keep refining your investment strategies and making those smart moves. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.Other helpful links:<ul style=\"list-style-type: disc;\"><li><a href=\"https://www.itiger.com/sg/help/detail/06324754?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"How to open a CBA.\" class=\"\">How to open a CBA.</a></li><li><a href=\"https://www.itiger.com/sg/help/detail/how-to-link-CDP?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"How to link your CDP account.\" class=\"\">How to link your CDP account.</a></li><li><a href=\"https://www.itiger.com/sg/help/detail/contra-faq?_sasdk=fNDE0MTg2NzAwNTE0OTk2Mg\" title=\"Other FAQs on CBA.\" class=\"\">Other FAQs on CBA.</a></li><li><a href=\"https://www.itiger.com/sg/invest/cash-boost\" title=\"Cash Boost Account Website.\" class=\"\">Cash Boost Account Website.</a><img src=\"https://community-static.tradeup.com/news/9cacb64c02a7bc16143db1b24ccaf6e6\" tg-width=\"1080\" tg-height=\"1080\"></li></ul>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/373078257447032"}